Coverage and Support | KESIMPTA® (ofatumumab) HCP

Local Coverage

KESIMPTA® (ofatumumab) coverage is better than ever!

[9 out of 10] patients with commercial insurance are covered, with [>80%] having first-line coverage. [$0] No out-of-pocket costs reported in [97%] of claims for commercially insured patients using the [$0] copay card. Patients don't wait weeks—start today with samples.

*Based on Managed Markets Insights & Technology, LLC database and data on file as of August 2025.¹
^†Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual copay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions at start.kesimpta.com.
^‡Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA and is intended to give patients a chance to see if KESIMPTA may be right for them.

Find Coverage

Explore coverage in your area with the interactive tool below

Novartis Patient Support

Novartis Patient Support is a comprehensive program designed to help your eligible patients start, stay, and save on KESIMPTA

Your practice and patients will have access to a Novartis Patient Support team committed to supporting your patients, including

Dedicated assistance with access and reimbursement
Support for your patients on KESIMPTA
Single points of contact for you and your patients

Support for your office

Access Reimbursement Manager

Helps navigate the prior authorization and appeals process
Troubleshoots any coverage or reimbursement issues

Resources available for your office

Support for your patients

Novartis Patient Support is a comprehensive program designed to help your patients start, stay, and save on KESIMPTA. Your patients can sign up once they have been prescribed KESIMPTA.

Patient Access Coordinator

Completes benefits verification
Informs the patient of coverage status and next steps

See more patient enrollment information

Dedicated Coordinator

Provides resources for and performs supplemental injection training
Provides 1-on-1 tailored support for up to 2 years

Access patient-friendly resources

“My [Coordinator] is there with me, every step of the way” – Jamie-Lynn Sigler. Award-winning actor, mom, KESIMPTA patient

Helpful Templates

Templates to help navigate insurance coverage

Looking for Prior Authorization forms? Visit the Getting Started page.

Contact your Sales Representative for a Sensoready® Demo Pen

Ready to start appropriate patients on KESIMPTA?

DOWNLOAD START FORM

Patients don't wait weeks—start today with samples

VISIT COVERMYMEDS

MS, multiple sclerosis.

References: 1. Data on file. Commercial coverage. Novartis Pharmaceuticals Corp; East Hanover, NJ. August 2025. 2. Data on file. 24 month first line coverage data. Novartis Pharmaceuticals Corp; East Hanover, NJ. July 2025. 3. Data on file. 97 percent OOP. Novartis Pharmaceuticals Corp; East Hanover, NJ. July 2024.